Stay updated on Nivolumab in Resectable Osteosarcoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.

Latest updates to the Nivolumab in Resectable Osteosarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 in the page footer.SummaryDifference0.0%

- Check28 days agoChange DetectedAdded institutional names and related footer links: Moffitt Cancer Center Clinical Trials website; H. Lee Moffitt Cancer Center and Research Institute; Helpful Links Provided by. Removed a government funding status notice that previously appeared on the page.SummaryDifference0.5%

- Check42 days agoChange DetectedAdded recent update timestamps to the Study Record Dates (2025-10-31, 2025-10-30, 2025-10) and removed older August timestamps (2025-08-05, 2025-08-04, 2025-08). These changes do not alter the study content, eligibility criteria, or outcomes.SummaryDifference0.5%

- Check71 days agoChange Detected- Added a government funding notice about potential delays and current operating status, plus a link to opm.gov for updates. - Added new Genetic and Rare Diseases Information Center resource: Bone osteosarcoma. - Version revision updated from v3.1.0 to v3.2.0.SummaryDifference4%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page revision has been updated to v3.0.2 (replacing v3.0.1); the 'Back to Top' link was removed, which is a minor UI change.SummaryDifference0.2%

Stay in the know with updates to Nivolumab in Resectable Osteosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.